Cover Image
Market Research Report
Product code
977304

Middle East and Africa Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 100 Pages | Delivery time: 3-5 business days

Price

Back to Top
Middle East and Africa Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 100 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

Middle East and Africa alopecia treatment (hair loss) market is projected to register a CAGR of 4.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Middle East and Africa Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Cicatricial Alopecia, Traction Alopecia and Others), Treatment (Localized Therapies, Systemic Therapies, Medical Devices and Herbal Treatment), Gender (Male and Female), Form (Oral, Topical and Parenteral), End User (Hospital, Home Healthcare and Dermatology Centers), Distribution Channel (Direct Tender, Retail Sales and Pharmacies), Country (Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of Middle East and Africa alopecia treatment (hair loss) market are:

Increasing prevalence of chemotherapy induced alopecia

Increasing level of stress

Market Players:

The key market players for Middle East and Africa alopecia treatment (hair loss) market are listed below:

Johnson & Johnson Services, Inc.

GlaxoSmithKline Plc.

Taisho Pharmaceutical Holdings Co., Ltd.

Sun Pharmaceutical Industries Ltd.

Pfizer Inc., Cipla Inc.

Aurobindo Pharma.

Abbott

Dr. Kurt Wolff Gmbh & Co. KG.

Dr. Reddy's Laboratories Ltd.

Gerolymatos International SA

Labo International S.R.L.

Perrigo Company Plc.

Vita-Cos-Med Klett-Loch Gmbh.

Wockhardt

Won Tech Co., Ltd.

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 DISEASE TYPE OF ALOPECIA TREATMENT (HAIR LOSS) LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET TREATMENT COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: REGULATIONS

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

7 IMPACT OF COVID 19 PANDEMIC ON THE MARKET

  • 7.1 PRICE IMPACT
  • 7.2 IMPACT ON SUPPLY CHAIN
  • 7.3 IMPACT ON DEMAND
  • 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
  • 7.5 CONCLUSION

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 INCREASE IN GERIATRIC POPULATION
    • 8.1.2 RISE IN PREVALENCE OF ALOPECIA CONDITIONS
    • 8.1.3 INCREASE IN PREVALENCE OF CHEMOTHERAPY INDUCED ALOPECIA
    • 8.1.4 INCREASING LEVEL OF STRESS
    • 8.1.5 CHANGING LIFESTYLES
  • 8.2 RESTRAINTS
    • 8.2.1 SIDE EFFECTS ASSOCIATED WITH THE AVAILABLE HAIR LOSS TREATMENT THERAPIES
    • 8.2.2 HIGH COST OF THERAPIES
    • 8.2.3 RECALL OF DRUG
  • 8.3 OPPORTUNITIES
    • 8.3.1 TECHNOLOGICAL ADVANCEMENTS IN HAIR TREATMENT MEDICAL DEVICES
    • 8.3.2 RISING DISPOSABLE INCOME
    • 8.3.3 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
    • 8.3.4 INCREASING AWARENESS REGARDING THE ALOPECIA (HAIR LOSS)
  • 8.4 CHALLENGES
    • 8.4.1 PATENT EXPIRATION
    • 8.4.2 IMPROPER REIMBURSEMENT POLICIES
    • 8.4.3 EXISTENCE OF ALTERNATIVE TREATMENT OPTIONS

9 MIDDLE EAST AND AFRICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE

  • 9.1 OVERVIEW
  • 9.2 NON-CICATRICIAL ALOPECIA
    • 9.2.1 ANDROGENIC ALOPECIA
    • 9.2.2 ALOPECIA AREATA
    • 9.2.3 ALOPECIA UNIVERSALIS
    • 9.2.4 ANAGEN ARREST/ANAGEN EFFLUVIUM
    • 9.2.5 TELOGEN EFFLUVIUM
  • 9.3 TRACTION ALOPECIA
  • 9.4 CIATRICIAL ALOPECIA
    • 9.4.1 FRONTAL FIBROSING ALOPECIA
    • 9.4.2 FOLLICULITIS DECALVANS
    • 9.4.3 LICHEN PLANOPILARIS
  • 9.5 OTHERS

10 MIDDLE EAST AND AFRICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY TREATMENT

  • 10.1 OVERVIEW
  • 10.2 LOCALIZED THERAPIES
    • 10.2.1 MINOXIDIL
    • 10.2.2 INTRALESIONAL CORTICOSTEROIDS
    • 10.2.3 TRIAMCINOLONE ACETONIDE
    • 10.2.4 HYDROCORTISONE ACETATE
    • 10.2.5 OTHERS
    • 10.2.6 TOPICAL CORTICOSTEROIDS
      • 10.2.6.1 Clobetasol Propionate
      • 10.2.6.2 Betamethasone Valerate
      • 10.2.6.3 Fluocinolone
      • 10.2.6.4 Dexamethasone
      • 10.2.6.5 Halcinonide
    • 10.2.7 FINASTERIDE
    • 10.2.8 ANTHRALIN
    • 10.2.9 TOPICAL IMMUNOTHERAPY
    • 10.2.10 MICRONUTRIENT SUPPLEMENTATION
      • 10.2.10.1 Vitamin A
      • 10.2.10.2 Vitamin D
      • 10.2.10.3 Iron
      • 10.2.10.4 Zinc
      • 10.2.10.5 Niacin
      • 10.2.10.6 Folic Acid
      • 10.2.10.7 Others
    • 10.2.11 OTHERS
  • 10.3 MEDICAL DEVICES
    • 10.3.1 LASER TREATMENT
      • 10.3.1.1 Hair Comb
      • 10.3.1.2 Wearable Laser Devices
      • 10.3.1.3 Cap
      • 10.3.1.4 Hair Band
      • 10.3.1.5 Helmet
      • 10.3.1.6 Machines
    • 10.3.2 HIGH POWER LED
    • 10.3.3 PHOTOTHERAPY
      • 10.3.3.1 Ultraviolet A-1
      • 10.3.3.2 Narrowband Ultraviolet B
  • 10.4 SYSTEMIC THERAPIES
    • 10.4.1 CORTICOSTEROIDS
    • 10.4.2 METHOTREXATE
    • 10.4.3 CYCLOSPORINE
    • 10.4.4 OTHERS
  • 10.5 HERBAL TREATMENT
    • 10.5.1 ALOE BARBADENSIS
    • 10.5.2 PHYLLANTHUS EMBELICA
    • 10.5.3 PRUNUS AMYGDALUS
    • 10.5.4 AVENA SATIVA
    • 10.5.5 AMARANTHUS SPINOSUS
    • 10.5.6 CAJANUS CAJAN
    • 10.5.7 DAUCUS CAROTA
    • 10.5.8 JUGLANS REGIA
    • 10.5.9 BACOPA MONNIERE
    • 10.5.10 MEDICAGO SATIVA
    • 10.5.11 LACTUCA SATIVA
    • 10.5.12 PELVETIA CANALICULATA
    • 10.5.13 OTHERS

11 MIDDLE EAST AND AFRICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY GENDER

  • 11.1 OVERVIEW
  • 11.2 MALE
  • 11.3 FEMALE

12 MIDDLE EAST AND AFRICA ALOPECIATREATMENT (HAIR LOSS) MARKET, BY FORM

  • 12.1 OVERVIEW
  • 12.2 TOPICAL
    • 12.2.1 CREAM
    • 12.2.2 SOLUTION
    • 12.2.3 OTHERS
  • 12.3 ORAL
    • 12.3.1 TABLET
    • 12.3.2 CAPSULES
    • 12.3.3 OTHERS
  • 12.4 PARENTERAL
    • 12.4.1 INTRAVENOUS
    • 12.4.2 INTRAMUSCULAR

13 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 DERMATOLOGY CENTERS
  • 13.3 HOSPITALS
  • 13.4 HOME HEALTHCARE

14 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 PHARMACIES
    • 14.2.1 OSPITAL
    • 14.2.2 RETAIL
    • 14.2.3 ONLINE
  • 14.3 RETAIL SALES
  • 14.4 DIRECT TENDER

15 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GEOGRAPHY

  • 15.1 MIDDLE EAST & AFRICA
    • 15.1.1 SAUDI ARABIA
    • 15.1.2 SOUTH AFRICA
    • 15.1.3 UAE
    • 15.1.4 ISRAEL
    • 15.1.5 KUWAIT
    • 15.1.6 EGYPT
    • 15.1.7 REST OF MIDDLE EAST & AFRICA

16 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

17 SWOT

18 COMPANY PROFILES

  • 18.1 JOHNSON & JOHNSON SERVICES, INC
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENTS
  • 18.2 GLAXOSMITHKLINE PLC
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENTS
  • 18.3 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENTS
  • 18.4 MERCK SHARP & DOHME CORP. (A SUBSIDIARY OF MERCK & CO., INC.)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENT
  • 18.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 PRODUCT PORTFOLIO
    • 18.5.4 RECENT DEVELOPMENTS
  • 18.6 PFIZER INC.
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 REVENUE ANALYSIS
    • 18.6.3 PRODUCT PORTFOLIO
    • 18.6.4 RECENT DEVELOPMENTS
  • 18.7 ZYDUS PHARMACEUTICALS, INC. (A SUBSIDIARY OF ZYDUS CADILA)
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 REVENUE ANALYSIS
    • 18.7.3 PRODUCT PORTFOLIO
    • 18.7.4 RECENT DEVELOPMENTS
  • 18.8 PAR PHARMACEUTICAL (A SUBSIDIARY OF ENDO INTERNATIONAL PLC)
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 REVENUE ANALYSIS
    • 18.8.3 PRODUCT PORTFOLIO
    • 18.8.4 RECENT DEVELOPMENTS
  • 18.9 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICALS INDUSTRIES LTD.)
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 REVENUE ANALYSIS
    • 18.9.3 PRODUCT PORTFOLIO
    • 18.9.4 RECENT DEVELOPMENTS
  • 18.10 CIPLA INC.
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 REVENUE ANALYSIS
    • 18.10.3 PRODUCT PORTFOLIO
    • 18.10.4 RECENT DEVELOPMENTS
  • 18.11 ALES GROUPE
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENTS
  • 18.12 AUROBINDO PHARMA
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 REVENUE ANALYSIS
    • 18.12.3 PRODUCT PORTFOLIO
    • 18.12.4 RECENT DEVELOPMENTS
  • 18.13 ABBOTT
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 REVENUE ANALYSIS
    • 18.13.3 PRODUCT PORTFOLIO
    • 18.13.4 RECENT DEVELOPMENTS
  • 18.14 CURALLUX, LLC.
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 DR. KURT WOLFF GMBH & CO. KG
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 BRAND PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 DR. REDDY'S LABORATORIES LTD.
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 PRODUCT PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENTS
  • 18.17 FREEDOM LASER THERAPY, INC.
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 PRODUCT PORTFOLIO
    • 18.17.3 RECENT DEVELOPMENTS
  • 18.18 FOLLICUM AB
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENTS
  • 18.19 GEROLYMATOS INTERNATIONAL SA
    • 18.19.1 COMPANY SNAPSHOT
    • 18.19.2 PRODUCT PORTFOLIO
    • 18.19.3 RECENT DEVELOPMENTS
  • 18.20 HCELL INC.
    • 18.20.1 COMPANY SNAPSHOT
    • 18.20.2 PRODUCT PORTFOLIO
    • 18.20.3 RECENT DEVELOPMENT
  • 18.21 IGROW LASER
    • 18.21.1 COMPANY SNAPSHOT
    • 18.21.2 PRODUCT PORTFOLIO
    • 18.21.3 RECENT DEVELOPMENTS
  • 18.22 LABO INTERNATIONAL S.R.L.
    • 18.22.1 COMPANY SNAPSHOT
    • 18.22.2 PRODUCT PORTFOLIO
    • 18.22.3 RECENT DEVELOPMENT
  • 18.23 LEXINGTON INTL., LLC.
    • 18.23.1 COMPANY SNAPSHOT
    • 18.23.2 PRODUCT PORTFOLIO
    • 18.23.3 RECENT DEVELOPMENTS
  • 18.24 NANOGEN
    • 18.24.1 COMPANY SNAPSHOT
    • 18.24.2 PRODUCT PORTFOLIO
    • 18.24.3 RECENT DEVELOPMENTS
  • 18.25 PERRIGO COMPANY PLC
    • 18.25.1 COMPANY SNAPSHOT
    • 18.25.2 REVENUE ANALYSIS
    • 18.25.3 PRODUCT PORTFOLIO
    • 18.25.4 RECENT DEVELOPMENTS
  • 18.26 PURETECH
    • 18.26.1 COMPANY SNAPSHOT
    • 18.26.2 REVENUE ANALYSIS
    • 18.26.3 PRODUCT PORTFOLIO
    • 18.26.4 RECENT DEVELOPMENTS
  • 18.27 VITABIOTICS LTD.
    • 18.27.1 COMPANY SNAPSHOT
    • 18.27.2 PRODUCT PORTFOLIO
    • 18.27.3 RECENT DEVELOPMENTS
  • 18.28 VITA-COS-MED KLETT-LOCH GMBH
    • 18.28.1 COMPANY SNAPSHOT
    • 18.28.2 PRODUCT PORTFOLIO
    • 18.28.3 RECENT DEVELOPMENT
  • 18.29 VIVISCAL LIMITED (A SUBSIDIARY OF CHURCH & DWIGHT CO.)
    • 18.29.1 COMPANY SNAPSHOT
    • 18.29.2 REVENUE ANALYSIS
    • 18.29.3 PRODUCT PORTFOLIO
    • 18.29.4 RECENT DEVELOPMENT
  • 18.30 WATERMANS
    • 18.30.1 COMPANY SNAPSHOT
    • 18.30.2 PRODUCT PORTFOLIO
    • 18.30.3 RECENT DEVELOPMENT
  • 18.31 WOCKHARDT
    • 18.31.1 COMPANY SNAPSHOT
    • 18.31.2 REVENUE ANALYSIS
    • 18.31.3 PRODUCT PORTFOLIO
    • 18.31.4 RECENT DEVELOPMENTS
  • 18.32 WON TECH CO., LTD.
    • 18.32.1 COMPANY SNAPSHOT
    • 18.32.2 PRODUCT PORTFOLIO
    • 18.32.3 RECENT DEVELOPMENTS

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, PIPELINE ANALYSIS
  • TABLE 2 INCIDENCE OF ALOPECIA ASSOCIATED TO THE MAIN CHEMOTHERAPIC DRUG CATEGORIES
  • TABLE 3 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 MIDDLE EAST AND AFRICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 5 MIDDLE EAST AND AFRICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 6 MIDDLE EAST AND AFRICA TRACTION ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 7 MIDDLE EAST AND AFRICA CIATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 8 MIDDLE EAST AND AFRICA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 9 MIDDLE EAST AND AFRICA OTHERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 10 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 11 MIDDLE EAST AND AFRICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 MIDDLE EAST AND AFRICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 13 MIDDLE EAST AND AFRICA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 14 MIDDLE EAST AND AFRICA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 15 MIDDLE EAST AND AFRICA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 16 MIDDLE EAST AND AFRICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 17 MIDDLE EAST AND AFRICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 18 MIDDLE EAST AND AFRICA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 19 MIDDLE EAST AND AFRICA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 20 MIDDLE EAST AND AFRICA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 21 MIDDLE EAST AND AFRICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 22 MIDDLE EAST AND AFRICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 23 MIDDLE EAST AND AFRICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 24 MIDDLE EAST AND AFRICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 25 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER, 2018-2027 (USD MILLION)
  • TABLE 26 MIDDLE EAST AND AFRICA MALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 27 MIDDLE EAST AND AFRICA FEMALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 28 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 29 MIDDLE EAST AND AFRICA TOPICAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 30 MIDDLE EAST AND AFRICA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 31 MIDDLE EAST AND AFRICA ORAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 33 MIDDLE EAST AND AFRICA PARENTERAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 34 MIDDLE EAST AND AFRICA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 35 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 36 MIDDLE EAST AND AFRICA DERMATOLOGY CENTERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 37 MIDDLE EAST AND AFRICA HOSPITALS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 38 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 39 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 MIDDLE EAST AND AFRICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 41 MIDDLE EAST AND AFRICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 42 MIDDLE EAST AND AFRICA RETAIL SALES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 43 MIDDLE EAST AND AFRICA DIRECT TENDER IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 44 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 45 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 46 MIDDLE EAST & AFRICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 47 MIDDLE EAST & AFRICA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 48 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 49 MIDDLE EAST & AFRICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 50 MIDDLE EAST & AFRICA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 51 MIDDLE EAST & AFRICA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 52 MIDDLE EAST & AFRICA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 53 MIDDLE EAST & AFRICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 54 MIDDLE EAST & AFRICA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 55 MIDDLE EAST & AFRICA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 56 MIDDLE EAST & AFRICA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 57 MIDDLE EAST & AFRICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 58 MIDDLE EAST & AFRICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 59 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 60 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 61 MIDDLE EAST & AFRICA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 62 MIDDLE EAST & AFRICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 63 MIDDLE EAST & AFRICA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 64 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 65 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 66 MIDDLE EAST & AFRICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 67 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 68 SAUDI ARABIA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 69 SAUDI ARABIA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 70 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 71 SAUDI ARABIA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 72 SAUDI ARABIA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 73 SAUDI ARABIA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 74 SAUDI ARABIA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 75 SAUDI ARABIA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 76 SAUDI ARABIA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 77 SAUDI ARABIA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 78 SAUDI ARABIA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 79 SAUDI ARABIA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 80 SAUDI ARABIA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 81 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 82 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 83 SAUDI ARABIA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 84 SAUDI ARABIA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 85 SAUDI ARABIA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 86 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 87 SAUDI ARABIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 88 SAUDI ARABIA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 89 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 90 SOUTH AFRICA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 91 SOUTH AFRICA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 92 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 93 SOUTH AFRICA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 94 SOUTH AFRICA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 95 SOUTH AFRICA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 96 SOUTH AFRICA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 97 SOUTH AFRICA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 98 SOUTH AFRICA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 99 SOUTH AFRICA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 100 SOUTH AFRICA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 101 SOUTH AFRICA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 102 SOUTH AFRICA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 103 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 104 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 105 SOUTH AFRICA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 106 SOUTH AFRICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 107 SOUTH AFRICA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 108 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 109 SOUTH AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 110 SOUTH AFRICA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 111 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 112 UAE NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 113 UAE CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 114 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 115 UAE LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 116 UAE INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 117 UAE TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 118 UAE MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 119 UAE MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 120 UAE LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 121 UAE WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 122 UAE PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 123 UAE SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 124 UAE HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 125 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 126 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 127 UAE TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 128 UAE ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 129 UAE PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 130 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 131 UAE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 132 UAE PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 133 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 134 ISRAEL NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 135 ISRAEL CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 136 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 137 ISRAEL LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 138 ISRAEL INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 139 ISRAEL TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 140 ISRAEL MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 141 ISRAEL MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 142 ISRAEL LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 143 ISRAEL WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 144 ISRAEL PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 145 ISRAEL SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 146 ISRAEL HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 147 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 148 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 149 ISRAEL TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 150 ISRAEL ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 151 ISRAEL PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 152 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 153 ISRAEL ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 154 ISRAEL PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 155 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 156 KUWAIT NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 157 KUWAIT CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 158 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 159 KUWAIT LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 160 KUWAIT INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 161 KUWAIT TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 162 KUWAIT MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 163 KUWAIT MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 164 KUWAIT LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 165 KUWAIT WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 166 KUWAIT PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 167 KUWAIT SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 168 KUWAIT HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 169 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 170 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 171 KUWAIT TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 172 KUWAIT ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 173 KUWAIT PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 174 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 175 KUWAIT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 176 KUWAIT PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 177 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 178 EGYPT NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 179 EGYPT CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 180 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 181 EGYPT LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 182 EGYPT INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 183 EGYPT TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 184 EGYPT MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 185 EGYPT MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 186 EGYPT LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 187 EGYPT WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 188 EGYPT PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 189 EGYPT SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 190 GYPT HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 191 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 192 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 193 EGYPT TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 194 EGYPT ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 195 EGYPT PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 196 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 197 EGYPT ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 198 EGYPT PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 199 REST OF MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 2 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 3 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: DROC ANALYSIS
  • FIGURE 4 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: MARKET TREATMENT COVERAGE GRID
  • FIGURE 10 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 12 INCREASE IN GERIATRIC POPULATION AND RISE IN PREVALENCE OF ALOPECIA CONDITIONS IS DRIVING THE MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 13 NON-CICATRICIAL ALOPECIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET IN 2020 & 2027
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • FIGURE 15 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR ALOPECIA TREATMENT (HAIR LOSS) MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 16 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019
  • FIGURE 17 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019-2027 (USD MILLION)
  • FIGURE 18 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, CAGR (2020-2027)
  • FIGURE 19 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, LIFELINE CURVE
  • FIGURE 20 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019
  • FIGURE 21 LOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
  • FIGURE 22 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, CAGR (2020-2027)
  • FIGURE 23 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, LIFELINE CURVE
  • FIGURE 24 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019
  • FIGURE 25 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019-2027 (USD MILLION)
  • FIGURE 26 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, CAGR (2020-2027)
  • FIGURE 27 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, LIFELINE CURVE
  • FIGURE 28 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019
  • FIGURE 29 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019-2027 (USD MILLION)
  • FIGURE 30 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, CAGR (2020-2027)
  • FIGURE 31 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, LIFELINE CURVE
  • FIGURE 32 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019
  • FIGURE 33 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 34 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 35 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 37 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 38 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 39 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 40 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: SNAPSHOT (2019)
  • FIGURE 41 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019)
  • FIGURE 42 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 43 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 44 MIDDLE EAST & AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TYPE (2020-2027)
  • FIGURE 45 MIDDLE EAST AND AFRICA ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY SHARE 2019 (%)